Osanni Bio

Ollin Bio

This biotechnology company develops bispecific antibody therapies for patients with vision-threatening conditions such as macular degeneration and thyroid eye disease.

Oculis

This biopharmaceutical company develops topical therapies and delivery systems to treat neuro-ophthalmic and ophthalmic diseases for patients with unmet medical needs.

Character Biosciences

This company develops precision medicines and companion diagnostics for degenerative eye diseases, serving patients and pharmaceutical partners.

Ollin Biosciences

This biopharmaceutical company develops bispecific antibody therapies for patients with vision-threatening ophthalmic conditions such as diabetic macular edema and age-related macular degeneration.

Omeicos Therapeutics

The company develops synthetic lipid mediators to treat patients with cardiovascular, ophthalmic and primary mitochondrial diseases.

Eyconis

The company develops long-acting ophthalmic medicines for patients with retinal diseases such as wet age-related macular degeneration.

Optherion

The company develops diagnostic tools and therapeutics for age-related macular degeneration and rare renal diseases for patients and healthcare providers.

EyeBio

This biotechnology company develops ocular therapies to treat retinal diseases such as diabetic macular edema and age-related macular degeneration for patients with vision loss.